Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation

References

• Bargman H, Hochman J. (2003). Topical treatment of Bowen’s disease with 5-FU. J Cutan Med Surg 7:101–5
   PubMed Web of Science ®Google Scholar
• Barreiro-Iglesias R, Alvarez-Lorenzo C, Concheiro A. (2001). Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J Control Release 77:59–75
   PubMed Web of Science ®Google Scholar
• Bendas ER, Tadros MI. (2007). Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech 8:E1–8
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G, Schatzlein A. (1997). Transfersomes mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Release 45:211–26
   Web of Science ®Google Scholar
• Chen-Yu G, Chun-Fen Y, Qui-Lu L, et al. (2012). Development of quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm 430:292–8
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, et al. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 110:296–306
   PubMed Web of Science ®Google Scholar
• Draize J, Woodard G, Calvery H. (1944). Methods for the study of irritation and toxicity of substance applied to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90
   Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, et al. (2007). Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 123:148–54
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Williams AC, Barry BW. (2001). Skin delivery of 5-Fluorouracil from ultra deformable and traditional liposomes in vitro. J Pharm Pharmacol 53:1069–76
   PubMed Web of Science ®Google Scholar
• Epstein E. (1985). Fluorouracil paste treatment of thin basal cell carcinomas. Arch Dermatol 121:207–13
   PubMed Web of Science ®Google Scholar
• Fraile RJ, Baker LH, Buroker TR, et al. (1980). Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223–8
   PubMed Web of Science ®Google Scholar
• Fresta M, Villari A, Puglisi G, Cavallaro G. (1993). 5-Fluorouracil: various kinds of loaded liposomes: encapsulation efficiency, storage stability and fusogenic properties. Int J Pharm 99:145–56
   Web of Science ®Google Scholar
• Gabrijelcic V, Sentjurc M. (1995). Influence of hydrogels on liposome stability and on the transport of liposome entrapped substances into the skin. Int J Pharm 118:207–12
   Web of Science ®Google Scholar
• Garg T, Jain S, Singh HP, et al. (2008). Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation. Drug Deve Ind Pharm 34:1100–10
   PubMed Web of Science ®Google Scholar
• Gonzalez Sanchez JL, Flores Murrieta G, Chavez Brambila J, et al. (2002). Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms. Ginecol Obstet Mex 70:244–7
   PubMedGoogle Scholar
• Guo J, Ping Q, Sun G, Jiao C. (2000). Lecithin vesicular carriers for transdermal delivery of cyclosporine-A. Int J Pharm 194:201–7
   PubMed Web of Science ®Google Scholar
• Holland JF, Frei III E, Bast RC Jr et al. (eds.). (1997). Cancer medicine. Philadelphia, PA: Lea & Febiger, 924–48
   Google Scholar
• Hussain A, Samad A, Singh SK et al. (2014). Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv, Early Online 1–16. [Epub ahead of print]
   PubMedGoogle Scholar
• Jain S, Jain N, Bhadra D, et al. (2005). Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv 2:223–33
   PubMedGoogle Scholar
• Jain S, Tiwary AK, Jain NK. (2006). Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr Drug Deliv 3:157–66
   PubMedGoogle Scholar
• Jain SK, Gupta Y, Jain A, Rai K. (2008). Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 15:141–7
   PubMed Web of Science ®Google Scholar
• Lasch J, Laub P, Woblrab W. (1991). How deep do intact liposomes penetrate into human skin? J Control Release 18:55–8
   Web of Science ®Google Scholar
• Lopez C, Maza A, Coderch L, et al. (1998). Direct formation of mixed micelle in the solublization of phospholipid liposomes by Triton X-100. FEBS Lett 426:314–18
   PubMed Web of Science ®Google Scholar
• Mishra N, Gupta PN, Mahor S, et al. (2007). Liposomes as adjuvant for combination vaccines. Indian J Exp Biol 45:237–41
   PubMed Web of Science ®Google Scholar
• Niwa K, Tagami K, Lian Z, et al. (2003). Topical vidarabine or 5-fluorouracil treatment against persistent HPV in genital (pre)cancerous. Oncol Rep 10:1437–41
   PubMed Web of Science ®Google Scholar
• Nounuo MM, El-Khordagui LK, Khalafallah N. (2005). Release stability of 5-fluororacil concentrates, gels and lyophilized powder. Acta Pol Pharm 62:381–91
   PubMedGoogle Scholar
• Knowles PF, Marsh D. (1991). Magnetic resonance of membranes. Biochem J 274:625–41
   PubMed Web of Science ®Google Scholar
• Khurana S, Jain NK, Bedi PMS. (2013). Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 92:383–92
   PubMed Web of Science ®Google Scholar
• Osterlind A, Berthelsen JG, Abildgaard N. (1991). Risk of bilateral testicular germ cell tumor in Denmark: 1960–1984. J Natl Cancer Inst 83:1391–5
   PubMed Web of Science ®Google Scholar
• Özer AY. (1992). Stability studies on 5-FU liposomes. Drug Target Deliv 1:151–60
   Google Scholar
• Peters GJ, Lankelma J, Kok RM, et al. (1993). Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. Cancer Chemother Pharmacol 31:269–76
   PubMed Web of Science ®Google Scholar
• Tsukada S, Ueda S, Ukada R. (1984). Preparation of liposome encapsulated antitumor drugs relationship between lipophilicity of and in vitro drug release. Chem Pharm Bull 32:1929–35
   Web of Science ®Google Scholar
• Tutrone WD, Saini R, Caglar S, et al. (2003). Topical therapy for actinic keratoses I: 5-fluorouracil and imiquimod. Cutis 71:365–70
   PubMed Web of Science ®Google Scholar
• Yeom S, Shin BS, Han S. (2014). An electron spin resonance study of non-ionic surfactant vesicles (niosomes). Chem Phys Lipids 181:83–9
   PubMed Web of Science ®Google Scholar